Today a ground-breaking article demonstrating the potential of rVAR2-based isolation of Circulating Tumour Cells for diagnosis of multiple types of cancer was published in Nature Communications. The current methods for CTCs isolation are limited by insufficient specificity and sensitivity, which have challenged clinical implementation. The study published today, shows that the VAR2CSA malaria protein, which binds […]
On Monday 3rd June to Thursday 7th June, Cheif Operating Officer Andreas Linderoth Norlin, will attend the BIO International Convention in Boston, MA. It will be four days of exciting meetings to explore new opportunities for collaborations and partnerships in the field of cancer diagnostics.
VarCT’s Director of Discovery and Preclinical Development, Dr. Mette Ørskov Agerbæk, are to present new exciting data on capturing of CTCs at the 11th International Symposium on Minimal Residual Cancer in Montpellier, France. The poster, entitled “The rVAR2 malaria protein efficiently retrieves circulating tumor cells in a EpCAM-independent manner” and is on display at the congress in poster session 2 […]
On April 17th, VarCT Diagnostics will present new exciting data at this year’s AACR meeting in Chicago, IL. The abstract entitled “The VAR2CSA malaria protein efficiently retrieves CTCs from a broad spectrum of cancers” is the result of work conducted together with the companies academic partners in Denmark, Canada and the United Kingdom. Check out […]
Today we got the good news that VarCT Diagnostics together with Copenhagen University has been granted 1 million DKK over 3 years by Innovation Fund Denmark for an Industry PhD student (InnovationsFonden). We are very pleased to welcome our talented soon-to-be new PhD student Sara Regina Bang-Christensen to the project “Development of a platform for isolation […]
VarCT Diagnostics will take part in the 23rd annual BIO-Europe partnering conference, 6-8 November 2017, in Berlin (https://ebdgroup.knect365.com/bioeurope/). With a full meeting schedule we look forward to have many fruitful discussions with potential partners in the pharma and biotech industry. See you there!
It is with great pride we announce that CEO and Professor Ali Salanti, Department of Cellular and Molecular Medicine, on May 24th 2017 recieved the prestigeous ERC Proof of Concept grant of Euro 150,000 over 18 months. The grant is an important contribution to our efforts to develop our novel methods for cancer diagnosis. For […]
Our website only uses strictly necessary cookies. Please consult our Privacy Policy for additional information on how we process your data.
